Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Drug Interaction Study to Investigate the Effects of Steady-State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Subjects

NCT01472380 is registered in ClinicalTrials.gov with Mutual Pharmaceutical Company, Inc. as lead sponsor.

NCT NCT01472380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01472380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Drug Interaction Study to Investigate the Effects of Steady-State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Subjects
Lead sponsor
Mutual Pharmaceutical Company, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2011
Completion date
January 31, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy